Innovations That Are Changing Complement Disease Treatment
This market’s explosive growth is fueled by a desperate therapeutic void in conditions like Geographic Atrophy (GA), a leading cause of blindness, Paroxysmal Nocturnal Hemoglobinuria (PNH), a life-threatening blood disorder, and C3 Glomerulopathy (C3G), a rare kidney disease
